Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:23:29 EDT Wed 16 Oct 2024
Enter Symbol
or Name
USA
CA



Q:PRQR - PROQR THERAPEUTICS N V - https://www.proqr.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PRQR - Q0.51.78·2.000.11.8154.6872121.83  1.90  1.773.29  1.11Oct 15Oct 0715 min RT 2¢

Recent Trades - Last 10 of 212
Time ETExPriceChangeVolume
16:00:00Q1.81 44
16:00:00Q1.81 13
16:00:00Q1.81 24
15:59:54Q1.81 2
15:59:53Q1.81 8
15:59:52Q1.81 4
15:59:50Q1.81 16
15:57:57Q1.81 3
15:57:43Q1.81 16
15:57:42Q1.81 98

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-10-07 08:00U:PRQRNews ReleaseProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society
2024-09-10 16:30U:PRQRNews ReleaseProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference
2024-08-08 07:00U:PRQRNews ReleaseProQR Announces Second Quarter 2024 Operating and Financial Results
2024-06-18 08:00U:PRQRNews ReleaseProQR Announces Presentation on its Axiomer(TM) RNA Editing Technology at RNA Editing Summit
2024-05-09 07:00U:PRQRNews ReleaseProQR Announces First Quarter 2024 Operating and Financial Results
2024-05-08 08:00U:PRQRNews ReleaseProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer(TM) RNA Editing Program Targeting NTCP for Cholestatic Diseases
2024-04-23 07:00U:PRQRNews ReleaseProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024
2024-04-22 16:31U:PRQRNews ReleaseProQR Highlights Upcoming Presentations on Axiomer(TM) RNA Editing at ASGCT 27th Annual Meeting
2024-04-19 07:00U:PRQRNews ReleaseProQR Achieves Successful Defense of New Challenge to its Axiomer(TM) IP Portfolio
2024-03-13 07:00U:PRQRNews ReleaseProQR Announces Year End 2023 Operating and Financial Results
2024-02-15 07:00U:PRQRNews ReleaseProQR Announces Japanese Axiomer ¢ „ ¢ Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing
2024-01-19 07:00U:PRQRNews ReleaseProQR Highlights New Platform Data from Presentation on Axiomer ¢ „ ¢ RNA Editing Technology at Deaminet 2024
2024-01-05 07:00U:PRQRNews ReleaseProQR and Rett Syndrome Research Trust Join Forces with Axiomer ¢ „ ¢ RNA Editing Collaboration
2023-12-08 07:30U:PRQRNews ReleaseProQR Therapeutics Announces Transaction Completed for Th ƒ ©a to Acquire Sepofarsen and Ultevursen Ophthalmic Assets
2023-11-07 07:00U:PRQRNews ReleaseProQR Announces Third Quarter 2023 Operating and Financial Results
2023-11-06 07:00U:PRQRNews ReleaseProQR Strengthens Leading Intellectual Property Estate for ADAR-mediated RNA Editing